Advertisement
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Advertisement

Purpose:

We review the current literature regarding urological management of spina bifida from prenatal diagnosis to adulthood.

Materials and Methods:

We searched MEDLINE®, EMBASE® and PubMed® for English articles published through December 2014 using search terms “spina bifida,” “spinal dysraphism” and “bladder.” Based on review of titles and abstracts, 437 of 1,869 articles were identified as addressing topics related to open spina bifida in pediatric patients, or long-term or quality of life outcomes in adults with spina bifida. We summarize this literature to inform clinical guidelines and create a framework for disease management.

Results:

The birth prevalence of spina bifida in the United States has recently plateaued at approximately 30 per 100,000. With improved management more individuals are surviving to adulthood, with an economic impact of $319,000 during the lifetime of an individual with spina bifida. Recent advances in prenatal surgery have demonstrated that prenatal closure of spina bifida is possible. To assess safety and efficacy, the National Institutes of Health sponsored Management of Myelomeningocele Study was undertaken, in which subjects were randomized to prenatal or postnatal closure. Until the urological results of this trial are published, the impact of prenatal intervention on future bladder function remains unclear. Controversy continues regarding the optimal use and timing of urodynamic studies, and the indications for initiation of clean intermittent catheterization and anticholinergics in infants and children. Many favor expectant management, while others argue for a more proactive approach. Based on the current literature, both approaches appear to protect the child from renal injury, although delayed intervention may increase rates of bladder augmentation. The current literature regarding this topic is difficult to interpret and compare due to heterogeneity of patient populations, variable outcome measures and lack of reporting of quality of life outcomes. Surgical intervention is indicated for those at risk for renal deterioration and/or is considered for children who fail to achieve satisfactory continence with medical management. Traditionally surgery concentrates on the bladder and bladder neck, and creation of catheterizable channels. For those with a hostile bladder, enterocystoplasty remains the gold standard for bladder augmentation, although use of bowel for augmentation remains suboptimal due to secondary complications, including increased risk of infections, metabolic abnormalities, neoplastic transformation and risk of life threatening perforation. Recent advances in tissue engineering technology may provide an alternative to traditional augmentation. However, recent results from phase II trials using current techniques to augment the bladder with engineered bladder tissue are disappointing. Catheterizable channels to the bladder and ascending colon further facilitate continence measures and promote independent care. While surgical reconstruction is clearly successful in improving continence, recent outcome studies have questioned the true impact of this type of surgery on quality of life. With improved survival transitional care issues, including health related independence, sexual health needs and development of a support system, are increasingly important. Transitional care remains a significant issue for which few public health measures are being quantitatively evaluated.

Conclusions:

Despite consensus regarding early urological involvement in the care of patients with spina bifida, controversy remains regarding optimal management. Major reconstructive urological surgeries still have a major role in the management of these cases to protect the upper urinary tract and to achieve continence. However, future studies are needed to better clarify the true impact on quality of life that these interventions have on patients and their families. Transition of urological care to adulthood remains a major avenue for improvement in disease management.

References

  • 1 : Contemporary epidemiological trends in complex congenital genitourinary anomalies. J Urol2013; 190: 1590. LinkGoogle Scholar
  • 2 : Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol2007; 79: 552. Google Scholar
  • 3 : Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol2010; 52: 749. Google Scholar
  • 4 : Implications of antenatal ultrasound screening in the incidence of major genitourinary malformations. Semin Pediatr Surg2001; 10: 204. Google Scholar
  • 5 : Antenatal ultrasound and magnetic resonance imaging in localizing the level of lesion in spina bifida and correlation with postnatal outcome. Ultrasound Obstet Gynecol2006; 27: 530. Google Scholar
  • 6 : A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med2011; 364: 993. Google Scholar
  • 7 : Long-term urological impact of fetal myelomeningocele closure. J Urol2011; 186: 1581. LinkGoogle Scholar
  • 8 : In utero closure of myelomeningocele does not improve lower urinary tract function. J Urol2012; 188: 1567. LinkGoogle Scholar
  • 9 : Urological results after fetal myelomeningocele repair in pre-MOMS trial patients at the Children’s Hospital of Philadelphia. Fetal Diagn Ther2015; 37: 211. Google Scholar
  • 10 : The timing of primary neurosurgical repair significantly affects neurogenic bladder prognosis in children with myelomeningocele. J Urol2006; 176: 1161. LinkGoogle Scholar
  • 11 : Predictors of parenting stress in mothers of children with spina bifida. Spinal Cord2011; 49: 376. Google Scholar
  • 12 : Oxybutynin chloride inhibits proliferation and suppresses gene expression in bladder smooth muscle cells. J Urol1999; 162: 1110. LinkGoogle Scholar
  • 13 : Detrusor overactivity in spina bifida: how long does it need to be treated?. Neurourol Urodyn2004; 23: 685. Google Scholar
  • 14 : Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele. J Urol2007; 178: 1479. LinkGoogle Scholar
  • 15 : Patients with spina bifida and bladder cancer: atypical presentation, advanced stage and poor survival. J Urol2007; 178: 798. LinkGoogle Scholar
  • 16 : Cumulative incidence of outcomes and urologic procedures after augmentation cystoplasty. J Pediatr Urol2014; 10: 1043. Google Scholar
  • 17 : Incidence of new onset metabolic acidosis following enteroplasty for myelomeningocele. J Urol2010; 183: 302. LinkGoogle Scholar
  • 18 : Outcome of gastrocystoplasty in tertiary pediatric urology practice. J Urol2000; 164: 947. LinkGoogle Scholar
  • 19 : Metastatic adenocarcinoma after augmentation gastrocystoplasty. J Urol2008; 179: 1094. LinkGoogle Scholar
  • 20 : Multi-institutional experience with the gastrointestinal composite reservoir. J Urol2001; 165: 2018. LinkGoogle Scholar
  • 21 : Ureterocystoplasty: indications for a successful augmentation. J Urol2004; 171: 376. LinkGoogle Scholar
  • 22 : Long-term fate of the bladder after isolated bladder neck procedure. J Pediatr Urol2014; 10: 886. Google Scholar
  • 23 : New hydronephrosis and/or vesicoureteral reflux after bladder outlet surgery without augmentation in 75 children with neurogenic bladder. J Pediatr Urol2014; 10: 906. Google Scholar
  • 24 : Assessing health related benefit after reconstruction for urinary and fecal incontinence in children: a parental perspective. J Urol2015; 193: 2073. LinkGoogle Scholar
  • 25 : A long continent ileovesicostomy using a single piece of bowel. J Urol1999; 162: 1743. LinkGoogle Scholar
  • 26 : Long-term followup and outcome of continent catheterizable vesicostomy using the Rink modification. J Urol2002; 168: 2583. LinkGoogle Scholar
  • 27 : L stent for stomal stenosis in catheterizable channels. J Urol2009; 182: 1786. LinkGoogle Scholar
  • 28 : High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord2005; 43: 331. Google Scholar
  • 29 : Transanal irrigation in myelomeningocele children: an alternative, safe and valid approach for neurogenic constipation. Spinal Cord2010; 48: 560. Google Scholar
  • 30 : The Malone antegrade continence enema procedure: quality of life and family perspective. J Urol2003; 169: 320. LinkGoogle Scholar
  • 31 : Appendiceal versus ileal segment for antegrade continence enema. J Urol2002; 167: 683. LinkGoogle Scholar
  • 32 : Longterm outcomes of “continence” surgery in neuropathic bladder. J Pediatr Urol2010; 6: S43. Google Scholar
  • 33 : Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol2003; 169: 195. LinkGoogle Scholar
  • 34 : Health related quality of life in patients with spina bifida: a prospective assessment before and after lower urinary tract reconstruction. J Urol2009; 182: 1984. LinkGoogle Scholar
  • 35 : Satisfaction after bowel and bladder reconstructive surgery for continence in the pediatric population. J Urol2012; 187: e485. abstract 1197. LinkGoogle Scholar
  • 36 : The conceptualization and development of a patient-reported neurogenic bladder symptom score. Res Rep Urol2013; 5: 129. Google Scholar
  • 37 : Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: phase II study in children and adolescents with spina bifida. J Urol2014; 191: 1389. LinkGoogle Scholar
  • 38 : Cotransplantation with specific populations of spina bifida bone marrow stem/progenitor cells enhances urinary bladder regeneration. Proc Natl Acad Sci U S A2013; 110: 4003. Google Scholar
  • 39 : Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol2009; 5: 156. Google Scholar
  • 40 : Intravesical electrotherapy for neurogenic bladder dysfunction: a 22-year experience. J Urol2007; 178: 1680. LinkGoogle Scholar
  • 41 : An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida. J Urol2005; 173: 2112. LinkGoogle Scholar
  • 42 : US pilot study of lumbar to sacral nerve rerouting to restore voiding and bowel function in spina bifida: 3-year experience. Adv Urol2014; 2014: 863209. Google Scholar
  • 43 : Evaluating functional and health outcomes for patients with spina bifida 5 and 10 years post-transition into adult care. Cerebrospinal Fluid Res2010; 7: S27. Google Scholar
  • 44 : A camp-based psychosocial intervention to promote independence and social function in individuals with spina bifida: moderators of treatment effectiveness. J Pediatr Psychol2013; 38: 412. Google Scholar
  • 45 : Interrelationships of sex, level of lesion, and transition outcomes among young adults with myelomeningocele. Dev Med Child Neurol2011; 53: 647. Google Scholar
  • 46 : Sex education, relationships, and sexuality in young adults with spina bifida. Arch Phys Med Rehabil2005; 86: 979. Google Scholar
  • 47 : Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol2000; 164: 958. LinkGoogle Scholar
  • 48 : Needs of children with a chronic bladder in preparation for transfer to adult care. J Pediatr Urol2013; 9: 509. Google Scholar
  • 49 : Transitional care in patients with congenital neurogenic bladder: an experience of bipolar spina bifida center. Neurourol Urodyn2014; 33: S34. Google Scholar